Outcome of bleomycin electrosclerotherapy of slow-flow malformations in adults and children

ConclusionsBEST is effective for treating slow-flow vascular malformations, with few but potentially significant major complications. Regarding patient-reported outcomes, children seem to benefit better compared to older patients, suggesting that BEST should not be restricted to adults.Clinical relevance statementBleomycin electrosclerotherapy is a safe and effective approach and therapy should not be restricted to adults due to good clinical outcomes in children.

Source: European Radiology - April 16, 2024 Category: Radiology Source Type: research